电子健康首先是一个IT平台,以支持决策的健康管理,长寿,诊断,预防和治疗常见疾病的非专业用户,医学专家,研究人员和企业的,基于blockchain技术,整机领域学习,自然语言分析,神经网络,大数据,临床流行病学,循证医学和远程医疗。 EHF是一个内置扩展的平台。在整个平台的核心是一个数据库 - 一个知识库 - 医学文献。该平台目前包括两个应用程序,通过使用人工智能和自然语言处理快速引用此文献必要的医疗信息的功能。第一个应用程序是一个消费级家用诊断及医疗的推荐应用。用户完成最初的医疗检查,并接受他们的健康进行全面初步分析,与用于治疗或用活医师会诊的建议。

代币基本信息

状态
已成功
货币符号
EHF
开始日期
2018-03-18
结束日期
2018-04-18
目标下限
8,000 ETH
目标上限
259,000 ETH
初始价格
1 EHF = 0.01 ETH
代币数
80,000,000
官网 Owner of eHealth First?
Claim this listing and publish updates.

基本信息

平台Ethereum
类型ERC20
接受币种ETH, BTC, Fiat
流通百分比80 %
KYC未知
受限地域未知
网站首页链接
白皮书下载

折扣信息

  • Private Placement - 50-70%
  • Pre-ICO - 40%

项目介绍

The eHealth First Platform and TokenEHF is a platform that is built to expand. At the core of the entire platform is a database - a knowledgebase - of medical literature. The platform currently includes two apps that function by using AI and natural language processing to quickly reference necessary medical information from this literature.The first app is a consumer grade home diagnosis and medical recommendation app. The user simply downloads the app to their smartphone (or opens the web portal on their PC), completes an intuitive initial medical screening, and receives a thorough preliminary analysis of their health, along with recommendations for treatment or consultation with a live physician.Based on the data gathered during the screening, the user may be offered the opportunity to pay, using EHF tokens or fiat, to purchase additional screenings for certain specific body systems. If you have a chronic skin condition, for example, you may choose to pay for the skin analysis module.The second app is an open platform for health professionals and developers. It is a direct means by which to access - quickly and easily - the medical literature and find answers that can improve patient outcomes. Of course, for full access of this app, the EHF token is essential. Developers can use the app to develop new software in the discipline.The EHF TokenThe main utility of the EHF token is to pay for services on the platform. Services can be paid for in fiat or tokens, but EHF transactions mean a 30% discount for the user.EHF token holders, in proportion to the number of tokens that they own, will be able to vote regarding certain decisions about the platform. However, the token does not represent ownership or a stake in the platform, or the right to have a vote.As demand for the platform increases, it is expected that the token’s value will increase. It will be available on various exchanges around the world.Financial indicatorseHealth First Project has high financial indicators, naming (for the conservative scenario) NPV(12%,10 y)=600 mln USD, IRR>50%, EV(Y2023)=1.4 bln. USD.The EHF TeamOur well-developed team (21 professionals from 8 countries) is headed by Nickolay Kryuchkov, an entrepreneur, researcher and medical doctor, and consists of experts in biomedical systems Arnold Mitnitsky and Sviatoslav Plavinsky, consultants in Health care and Public Health Policy Daria Khaltourina, Nick Guldemond, Edwina Rogers and Artem Gill, a biomedical gerontologist Aubrey De Grey, experts in genomics, longevity and aging João Pedro de Magalhães, Kalluri Subba Rao, Oliver Medvedik, physician and clinical researcher Lyle Dennis, researchers and engineers in blockchain development, machine learning, artificial intelligence Eray Ozkural, Artemy Malkov, Keith Comito, attorney at law Paul Spiegel, financial expert Victor Solntsev and more.
Participate in the ICOThe EHF token is of the ERC20 standard. The ICO will begin soon. A soft cap has been set at 8,000 ETH.The private placement phase of the ICO is in full gear. You can currently buy tokens at the lowest price they will ever be available with huge bonuses. Bonuses of 45-70% are available.You can participate at www.ehfirst.ioThe Pre-ICO will begin March 18th and end April 18th. Bonuses of up to 40% will be available.Join Twitter, Telegram, Facebook, and subscribe to our YouTube Channel for a new videoclip every day from Monday to Friday.Read the White Paper for all the details.

团队介绍 查看全部

Nickolay Kryuchkov
Nickolay Kryuchkov
Chief Executive Officer
Arnold Mitnitski
Arnold Mitnitski
Advisor in Mathematical Modeling of complex biomedical systems, Systems Biology of the aging process, Advanced Data Analysis.
Daria Khaltourina
Daria Khaltourina
Director, Public Health and Longevity Programs
Nick Guldemond
Nick Guldemond
Advisor in Health Policy and Management, Clinical Epidemiology, Public Policy, eHealth, Clinical Neurology, Clinical Diagnostics, Clinical Studies, Aging and Longevity Studies
Aubrey De Grey
Aubrey De Grey
Advisor in Biomedical Gerontology, Aging and Longevity Studies, Biotechnology, Drug Assessment, Health Promotion
Denis Rysev
Denis Rysev
C.T.O., Blockchain and Health Records